Showing results (31-40 of 183) with videos related to
Sort By:
Pageof 19
Biochemical Pharmacology|October 12, 1995
Competition between inhibitors of the trypanosome alternative oxidase (TAO) and reduced coenzyme Q9G Pollakis, R W Grady, H A Dieck, et al.The Journal of Experimental Medicine|August 1, 1978
An approach to the development of new drugs for African trypanosomiasisS R Meshnick, S H Blobstein, R W Grady, et al.British Journal of Haematology|March 1, 1976
Inhibition of membrane peroxidation in thalassaemic erythrocytes by 2,3-dihydroxybenzoic acidJ H Graziano, D R Miller, R W Grady, et al.The Journal of Experimental Medicine|February 1, 1980
Low molecular weight iron-binding factor from mammalian tissue that potentiates bacterial growthR L Jones, C M Peterson, R W Grady, et al.The Journal of Biological Chemistry|October 25, 1989
Respiration of bloodstream forms of the parasite Trypanosoma brucei brucei is dependent on a plant-like alternative oxidaseA B Clarkson, E J Bienen, G Pollakis, et al.Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1989
Trypanocidal CoQ analogues: their effect on other mitochondrial systemsA B Clarkson, E J Bienen, G Pollakis, et al.The Journal of Laboratory and Clinical Medicine|May 1, 1986
Host-associated iron transfer factor in normal humans and patients with transfusion siderosisR L Jones, R W Grady, M P Sorette, et al.The Journal of Pharmacology and Experimental Therapeutics|February 1, 1976
The development of new iron-chelating drugsR W Grady, J H Graziano, H A Akers, et al.American Journal of Clinical Pathology|December 1, 1989
Cytoferrin, maternofetal iron transport, and neonatal hemochromatosisA S Knisely, R W Grady, E E Kramer, et al.Clinical and Experimental Immunology|November 1, 1985
Immunological abnormalities in thalassaemia major. I. A transfusion-related increase in circulating cytoplasmic immunoglobulin-positive cellsA N Akbar, P J Giardina, M W Hilgartner, et al.Pageof 19